Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.2K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.8K
1.8K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

7.6K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.6K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

4.4K
4.4K
Tumor Immunotherapy01:27

Tumor Immunotherapy

2.6K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.6K
Cancer Therapies02:49

Cancer Therapies

10.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Genomic Landscape of MYC, MYCL, and MYCN Amplified Solid Tumors.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Harnessing myeloid cell plasticity for cancer therapy.

Nature cancer·2026
Same author

Targeting the chromatin modifying enzyme, KDM5C, enhances AKT inhibition response in ER+ breast cancer.

Molecular cancer therapeutics·2026
Same author

Capivasertib Combines with Trastuzumab Deruxtecan to Enhance Antitumor Activity in HER2-Positive and HER2-Low Tumors.

Molecular cancer therapeutics·2026
Same author

Probing intratumoral metabolic compartmentalisation in a patient with fumarate hydratase-deficient renal cancer using clinical hyperpolarised <sup>13</sup>C-MRI and mass spectrometry imaging.

Communications medicine·2026
Same author

PARP inhibition generates enhanced CD8<sup>+</sup> central memory T cells by transcriptional and metabolic reprogramming.

Nature immunology·2026

Related Experiment Video

Updated: Apr 20, 2026

Author Spotlight: Integrating Computational and Experimental Approaches in Precision Oncology
07:03

Author Spotlight: Integrating Computational and Experimental Approaches in Precision Oncology

Published on: December 1, 2023

1.7K

Enabling AI to Drive Innovation and Precision across Oncology R&D.

Richard J A Goodwin1, Simon T Barry2, James Weatherall3

  • 1Predictive AI & Data, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca (United Kingdom), Cambridge, United Kingdom.

Cancer Discovery
|April 18, 2026
PubMed
Summary
This summary is machine-generated.

Integrating large-scale datasets with artificial intelligence (AI) is crucial for modern drug discovery. Investing in data infrastructure and AI accelerates the development of precision oncology therapeutics worldwide.

More Related Videos

Automating Tumor Implantation in Zebrafish Larvae for Cancer Research and Medicine
06:14

Automating Tumor Implantation in Zebrafish Larvae for Cancer Research and Medicine

Published on: September 19, 2025

1.2K
Enhancing Chimeric Antigen Receptor-Extracellular Vesicles (CAR-EV) Technology: The Future of Cancer Therapy
07:33

Enhancing Chimeric Antigen Receptor-Extracellular Vesicles (CAR-EV) Technology: The Future of Cancer Therapy

Published on: September 19, 2025

1.0K

Related Experiment Videos

Last Updated: Apr 20, 2026

Author Spotlight: Integrating Computational and Experimental Approaches in Precision Oncology
07:03

Author Spotlight: Integrating Computational and Experimental Approaches in Precision Oncology

Published on: December 1, 2023

1.7K
Automating Tumor Implantation in Zebrafish Larvae for Cancer Research and Medicine
06:14

Automating Tumor Implantation in Zebrafish Larvae for Cancer Research and Medicine

Published on: September 19, 2025

1.2K
Enhancing Chimeric Antigen Receptor-Extracellular Vesicles (CAR-EV) Technology: The Future of Cancer Therapy
07:33

Enhancing Chimeric Antigen Receptor-Extracellular Vesicles (CAR-EV) Technology: The Future of Cancer Therapy

Published on: September 19, 2025

1.0K

Area of Science:

  • Computational Biology
  • Bioinformatics
  • Artificial Intelligence in Medicine

Background:

  • Drug discovery and development face increasing complexity and cost.
  • The need for faster delivery of targeted therapies, particularly in oncology, is paramount.
  • Leveraging large-scale, multidomain datasets is a growing trend in pharmaceutical research.

Purpose of the Study:

  • To highlight the essential role of integrated large-scale, multidomain datasets and artificial intelligence (AI) in drug discovery and development.
  • To emphasize the strategic importance of data infrastructure and AI solutions for accelerating therapeutic delivery.
  • To underscore the global impact of these advancements on precision oncology.

Main Methods:

  • Integration of large-scale, multidomain datasets.
  • Application of artificial intelligence (AI) algorithms.
  • Strategic investment in data infrastructure and AI solutions.

Main Results:

  • AI-driven analysis of integrated datasets is essential for modern drug discovery.
  • Robust data infrastructure and tailored AI solutions significantly accelerate therapeutic development.
  • These advancements are key to delivering precision oncology therapeutics globally.

Conclusions:

  • Strategic investment in data infrastructure and AI is critical for pharmaceutical innovation.
  • The synergy between large-scale data and AI is transforming drug discovery and development.
  • Accelerated delivery of precision oncology treatments is achievable through these integrated approaches.